Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Colucci

Showing results (271-280 of 316) with videos related to

Pageof 32
Sort By:
Circulation|June 20, 2007
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trialWilson S Colucci, Theodore J Kolias, Kirkwood F Adams, et al.
Circulation|June 28, 2000
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failureM M Givertz, W S Colucci, T H LeJemtel, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
Osteoblast apoptosis in periodontal disease: role of TNF-related apoptosis-inducing ligandG Mori, G Brunetti, S Colucci, et al.
European Heart Journal|September 3, 2004
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart studyJohan Sundström, Jane C Evans, Emelia J Benjamin, et al.
Journal of the American College of Cardiology|July 10, 2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failureGuillermo Torre-Amione, James B Young, Wilson S Colucci, et al.
Circulation|April 11, 2001
Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarctionM Jain, H DerSimonian, D A Brenner, et al.
Circulation. Heart Failure|October 11, 2013
Nitroxyl (HNO): A novel approach for the acute treatment of heart failureHani N Sabbah, Carlo Gabriele Tocchetti, Mengjun Wang, et al.
Circulation|March 1, 1990
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathyC B Treasure, J A Vita, D A Cox, et al.
Circulation. Heart Failure|July 16, 2015
Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese IndividualsYi-Chih Wang, Chang-Seng Liang, Deepa M Gopal, et al.
The Canadian Journal of Cardiology|April 19, 2007
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designGuillermo Torre-Amione, Robert C Bourge, Wilson S Colucci, et al.
Pageof 32

Showing results (271-280 of 316) with videos related to

Sort By:
Pageof 32
Circulation|June 20, 2007
Metoprolol reverses left ventricular remodeling in patients with asymptomatic systolic dysfunction: the REversal of VEntricular Remodeling with Toprol-XL (REVERT) trialWilson S Colucci, Theodore J Kolias, Kirkwood F Adams, et al.
Circulation|June 28, 2000
Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failureM M Givertz, W S Colucci, T H LeJemtel, et al.
International Journal of Immunopathology and Pharmacology|March 25, 2009
Osteoblast apoptosis in periodontal disease: role of TNF-related apoptosis-inducing ligandG Mori, G Brunetti, S Colucci, et al.
European Heart Journal|September 3, 2004
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart studyJohan Sundström, Jane C Evans, Emelia J Benjamin, et al.
Journal of the American College of Cardiology|July 10, 2003
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failureGuillermo Torre-Amione, James B Young, Wilson S Colucci, et al.
Circulation|April 11, 2001
Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarctionM Jain, H DerSimonian, D A Brenner, et al.
Circulation. Heart Failure|October 11, 2013
Nitroxyl (HNO): A novel approach for the acute treatment of heart failureHani N Sabbah, Carlo Gabriele Tocchetti, Mengjun Wang, et al.
Circulation|March 1, 1990
Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathyC B Treasure, J A Vita, D A Cox, et al.
Circulation. Heart Failure|July 16, 2015
Preclinical Systolic and Diastolic Dysfunctions in Metabolically Healthy and Unhealthy Obese IndividualsYi-Chih Wang, Chang-Seng Liang, Deepa M Gopal, et al.
The Canadian Journal of Cardiology|April 19, 2007
A study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designGuillermo Torre-Amione, Robert C Bourge, Wilson S Colucci, et al.
Pageof 32